Project Number ADDF-52 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2021 View Full Project Details for Misfolded Alpha-Synuclein Aggregates in CSF as Diagnostic & Prognostic Markers for Dementia Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers a. CSF Biomarkers Researcher and Organization Principal Investigator Lebovitz, Russell Principal Investigator Lebovitz, Russell Awardee Organization AMPRION, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $631,600 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management